+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Brain Cancer: Epidemiology Forecast to 2027

  • ID: 4701898
  • Report
  • October 2018
  • Region: Global
  • 32 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3
Summary

Epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 119,717 cases in 2017 to 151,067 cases in 2027, at an Annual Growth Rate (AGR) of 2.62% in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and urban China). Urban China will have the highest number of diagnosed incident cases of brain cancer among the 8MM throughout the forecast period. The five-year diagnosed prevalent cases of brain cancer are also expected to increase from 220,839 cases in 2017 to 262,409 cases in 2027, at an AGR of 1.88%.

Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem. The American Brain Tumor Association (ABTA) reports that there are over 120 different types of malignant and benign brain tumors (ABTA, 2014). The type and severity of a brain tumor is defined by the cells from which the tumor originated, as well as by the proliferative potential of the abnormal growth. Only malignant tumors are designated as cancer. Primary brain tumors are those that start in the brain and may, in time, migrate elsewhere in the body, while metastatic brain tumors are those that start elsewhere in the body and migrate to the brain or other parts of the CNS.

"Additionally, it includes a forecast for the diagnosed incident cases of brain cancer segmented by type (glioblastoma, meningioma, ependymoma, oligodendroglioma, and CNS lymphoma). This forecast for brain cancer includes only primary malignant brain tumors originating in the CNS (ICD-10 codes C70-C72).

Scope
  • The brain cancer Epidemiology Forecast Report provides an overview of the risk factors and global trends brain cancer in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China).
  • This report also includes a 10-year epidemiological forecast for the following segmentations in all ages across the 8MM: diagnosed incident cases of brain cancer; five-year diagnosed prevalent cases; diagnosed incident cases of brain cancer type; and diagnosed incident cases of brain cancer with associated biomarkers.
  • The brain cancer epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to Buy

The Brain Cancer Epidemiology Forecast report will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global brain cancer market.
  • Quantify patient populations in the global brain cancer market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for brain cancer therapeutics in each of the markets covered.
  • Understand magnitude of brain cancer population by associated biomarkers.
Note: Product cover images may vary from those shown
2 of 3
1. Table of Contents
List of Tables
List of Figures

2. Brain Cancer: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports

3. Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for Brain Cancer (2017-2027)
3.5.1 Diagnosed Incident Cases of Brain Cancer
3.5.2 Age-Specific Diagnosed Incident Cases of Brain Cancer
3.5.3 Sex-Specific Diagnosed Incident Cases of Brain Cancer
3.5.4 Five-Year Diagnosed Prevalent Cases of Brain Cancer
3.5.5 Diagnosed Incident Cases of Brain Cancer by Type
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis

4. Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Description of Brain Cancer Types

List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of Brain Cancer, Men and Women, All Ages, 2017 and 2027
Figure 2: 8MM, Five-Year Diagnosed Prevalent Cases of Brain Cancer, Men and Women, All Ages, 2017 and 2027
Figure 3: 8MM, Age-Standardized Diagnosed Incidence of Brain Cancer, Men and Women, All Ages, 2017
Figure 4: Sources Used and Not Used to Forecast Diagnosed Incident Cases of Brain Cancer
Figure 5: Sources Used and Not Used to Forecast the Five-Year Diagnosed Prevalent Cases of Brain Cancer
Figure 6: Sources Used to Forecast Diagnosed Incident Cases of Brain Cancer by Type
Figure 7: 8MM, Diagnosed Incident Cases of Brain Cancer, Men and Women, All Ages, 2017
Figure 8: 8MM, Age-Specific Diagnosed Incident Cases of Brain Cancer, Men and Women, 2017, N
Figure 9: 8MM, Sex-Specific Diagnosed Incident Cases of Brain Cancer, Men and Women, All Ages, 2017
Figure 10: 8MM, Five-Year Diagnosed Prevalent Cases of Brain Cancer, Men and Women, All Ages, 2017
Figure 11: 8MM, Diagnosed Incident Cases of Brain Cancer by Type, Men and Women, All Ages, 2017, N
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

Adroll
adroll